In symptomatic peripheral artery disease with T2D, semaglutide increased maximum walking distance at 1 y.
Where this comes from
- Record sourced from PubMed, PMID 40889359.
- Also identified by DOI 10.7326/ANNALS-25-03196-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text].
Medical subject headings
- Peripheral Arterial Disease
- Glucagon-Like Peptides
- Walking
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents